Very true Gajet. The other key aspect of performance shares or KPI is how the directors performance is to be measured. I like to see these goals stated as a nominated SP value to be achieved by a nominated future deadline. Shorting plays havoc with that method, but maybe that's just another obstacle that directors need to overcome if acting in the best interests of the company, other holders and themselves? NPAT is another measurement that's fair also.
- Forums
- ASX - By Stock
- Ann: Andover South Drilling Update
RDN
raiden resources limited
Add to My Watchlist
0.00%
!
0.4¢

Very true Gajet. The other key aspect of performance shares or...
Featured News
Add to My Watchlist
What is My Watchlist?
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
|
|||||
Last
0.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $13.80M |
Open | High | Low | Value | Volume |
0.4¢ | 0.5¢ | 0.4¢ | $30.16K | 7.387M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
85 | 49580103 | 0.4¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
0.5¢ | 17688676 | 19 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
79 | 46040603 | 0.004 |
39 | 35008156 | 0.003 |
14 | 26357501 | 0.002 |
8 | 32400001 | 0.001 |
0 | 0 | 0.000 |
Price($) | Vol. | No. |
---|---|---|
0.005 | 14112777 | 17 |
0.006 | 16249002 | 26 |
0.007 | 18059066 | 30 |
0.008 | 8873282 | 10 |
0.009 | 6900000 | 4 |
Last trade - 16.10pm 27/06/2025 (20 minute delay) ? |
Featured News
RDN (ASX) Chart |
The Watchlist
PAR
PARADIGM BIOPHARMACEUTICALS LIMITED..
Paul Rennie, MD & Founder
Paul Rennie
MD & Founder
SPONSORED BY The Market Online